Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis are associated with otitis media (OM). Indigenous children experience particularly high rates of OM. Few studies worldwide have described upper respiratory tract (URT) carriage in Indigenous and non-Indigenous children living in the same area.
The aim of this study was to describe URT bacterial carriage in Aboriginal and non-Aboriginal children in the Kalgoorlie-Boulder area, Western Australia, as part of an investigation into causal pathways to OM.
Five hundred four and 1045 nasopharyngeal aspirates were collected from 100 Aboriginal and 180 non-Aboriginal children, respectively, followed from birth to age 2 years. Standard procedures were used to identify bacteria.
Overall carriage rates of S. pneumoniae, M. catarrhalis and H. influenzae in Aboriginal children were 49%, 50% and 41%, respectively, and 25%, 25% and 11% in non-Aboriginal children. By age 2 months S. pneumoniae and M. catarrhalis had been isolated from 37% and 36% of Aboriginal children and from 11% and 12% of non-Aboriginal children, respectively. From age 3 months onward, carriage rates in Aboriginal children were 51% to 67% for S. pneumoniae and M. catarrhalis and 42% to 62% for H. influenzae; corresponding figures for non-Aboriginal children were 26% to 37% for S. pneumoniae and M. catarrhalis and 11% to 18% for H. influenzae. Non-Aboriginal children had higher carriage rates in winter than in summer, but season had little effect in Aboriginal children. Staphylococcus aureus carriage was highest under age 1 month (55% Aboriginal, 61% non-Aboriginal) and was always higher in non-Aboriginal than Aboriginal children.
Interventions are needed to reduce high transmission and carriage rates, particularly in Aboriginal communities, to avoid the serious consequences of OM.
From the *Telethon Institute for Child Health Research, Centre for Child Health Research, The University of Western Australia, Western Australia, Australia; the †Division of Microbiology & Infectious Diseases, PathWest Laboratory Medicine, Western Australia, Australia; ‡Microbiology & Immunology, The University of Western Australia, Western Australia, Australia; and §Menzies School of Health Research and the Institute of Advanced Studies, Charles Darwin University, Darwin, Northern Territory, Australia.
Accepted for publication June 5, 2006.
This study was funded through National Health and Medical Research Council project grant 212044 and 2 Healthway grants (6028 and 10564). DL and KW are currently funded through NHMRC program grant 353514. World Vision provided funding for L. Dorizzi, R. Bonney and P. Bonney. Wyeth Australia provided Prevenar for non-Aboriginal study participants.
Address for correspondence: Associate Professor Deborah Lehmann, Division of Population Sciences, Telethon Institute for Child Health Research, P.O. Box 855, West Perth, WA 6872, Australia. E-mail: email@example.com.